Etanercept in the treatment of plaque psoriasis
Thao U Nguyen, John KooDepartment of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, San Francisco, California, USAAbstract: Etanercept is approved for the treatment of moderate to severe plaque psoriasis at a dose of 50 mg twice weekly for 3 months followe...
Saved in:
Main Authors: | Thao U Nguyen (Author), John Koo (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plaque psoriasis in children and adolescents – the role of etanercept
by: Ricceri F, et al.
Published: (2012) -
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece
by: Dimitris Rigopoulos, et al.
Published: (2022) -
Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update
by: Siegfried Segaert
Published: (2009) -
Psoriasis, lymphoma and etanercept: is there a correlation? Psoríase, linfoma e etanercepte: existe correlação?
by: Ludmilla Queirós Miranda, et al.
Published: (2012) -
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
by: Giorgio L Colombo, et al.
Published: (2009)